WIPI1 Antikörper (AA 35-84)
-
- Target Alle WIPI1 Antikörper anzeigen
- WIPI1 (WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1))
-
Bindungsspezifität
- AA 35-84
-
Reaktivität
- Human, Maus, Ratte, Pferd, Rind (Kuh), Kaninchen, Schwein, Fledermaus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser WIPI1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human WIPI1
- Homologie
- Percent identity by BLAST analysis: Human, Mouse, Rat, Rabbit, Pig (100%) Dog, Guinea pig, Chicken (92%) Bovine (85%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide located between aa35-84 of human WIPI1 (Q5MNZ9, NP_060453). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Bat, Rabbit, Horse, Pig (100%), Galago, Marmoset, Dog, Guinea pig, Turkey, Chicken (92%), Bovine, Opossum (85%).
Type of Immunogen: Synthetic peptide - Top Product
- Discover our top product WIPI1 Primärantikörper
-
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (AA 348-445) antibody
WIPI1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3C1 unconjugated
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (AA 187-446) antibodyWIPI1 Reaktivität: Human WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (Middle Region) antibodyWIPI1 Reaktivität: Human, Maus, Ratte, Pferd, Hund, Rind (Kuh), Meerschweinchen, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (AA 202-232) antibodyWIPI1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB18986 unconjugated
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (AA 32-59), (N-Term) antibodyWIPI1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB18985 unconjugated
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (AA 348-445) antibodyWIPI1 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2D1 unconjugated
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) (C-Term) antibodyWIPI1 Reaktivität: Human WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1) antibodyWIPI1 Reaktivität: Human WB Wirt: Kaninchen Monoclonal unconjugated
-
- Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Distilled water
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS with 2 % sucrose
- Handhabung
- Avoid repeat freeze-thaw cycles.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
- Target
- WIPI1 (WD Repeat Domain, phosphoinositide Interacting 1 (WIPI1))
- Andere Bezeichnung
- ATG18 / WIPI1 (WIPI1 Produkte)
- Hintergrund
-
Name/Gene ID: WIPI1
Synonyms: WIPI1, ATG18, Atg18 protein homolog, ATG18A, WIPI49, WIPI-1, WIPI 49 kDa, WIPI-1 alpha - Gen-ID
- 55062
- NCBI Accession
- NP_060453
- UniProt
- Q5MNZ9
- Pathways
- Nuclear Hormone Receptor Binding, ER-Nucleus Signaling
-
